5981 related articles for article (PubMed ID: 3586798)
1. [Attempts to produce human monoclonal antibodies to melanoma using the cervical lymph nodes].
Wilmes E; Funke I; Riethmüller G
Laryngol Rhinol Otol (Stuttg); 1987 Mar; 66(3):144-8. PubMed ID: 3586798
[TBL] [Abstract][Full Text] [Related]
2. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
4. Generation of human IgG, IgA, and IgM anti-melanoma monoclonal antibodies utilizing lymphocytes of an actively immunized melanoma patient.
Abdel-wahab ZA; Gillanders WE; Darrow TL; Seigler HF
Hum Antibodies Hybridomas; 1992 Jan; 3(1):32-9. PubMed ID: 1576321
[TBL] [Abstract][Full Text] [Related]
5. Human-human hybridomas generated with lymphocytes from patients with colorectal cancer.
Borup-Christensen P; Erb K; Jensenius JC; Svehag SE; Nielsen B
Cancer Detect Prev Suppl; 1987; 1():207-15. PubMed ID: 3480051
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
8. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.
Kjeldsen TB; Rasmussen BB; Rose C; Zeuthen J
Cancer Res; 1988 Jun; 48(11):3208-14. PubMed ID: 3365703
[TBL] [Abstract][Full Text] [Related]
9. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
[TBL] [Abstract][Full Text] [Related]
10. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibodies to nuclear antigens.
McKnight ME; Koda K; DeBoer K; Glassy MC
Hum Antibodies Hybridomas; 1990; 1(2):77-82. PubMed ID: 2103355
[TBL] [Abstract][Full Text] [Related]
12. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
14. Identification of melanoma-associated antigens using fixed tissue screening of antibodies.
Atkinson B; Ernst CS; Ghrist BF; Herlyn M; Blaszczyk M; Ross AH; Herlyn D; Steplewski Z; Koprowski H
Cancer Res; 1984 Jun; 44(6):2577-81. PubMed ID: 6722794
[TBL] [Abstract][Full Text] [Related]
15. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
16. Specific monoclonal antibodies reacting with human breast cancer cells.
Plessers L; Bosmans E; Cox A; Raus J
Anticancer Res; 1986; 6(5):885-8. PubMed ID: 2432833
[TBL] [Abstract][Full Text] [Related]
17. Immortalization of human lymphocytes from a tumor-involved lymph node.
Glassy MC
Cancer Res; 1987 Oct; 47(19):5181-8. PubMed ID: 3621203
[TBL] [Abstract][Full Text] [Related]
18. The WI-L2-729-HF2 human hybridoma system. Arrangement of lambda genes in monoclonal hybrids.
Heitzmann JG; Blomberg B; Cohn M
Mol Biol Med; 1986 Aug; 3(4):339-50. PubMed ID: 3095607
[TBL] [Abstract][Full Text] [Related]
19. The production of hybridomas from the gut associated lymphoid tissue of tumour bearing rats. I. Mesenteric nodes as a source of IgG producing cells.
Dean CJ; Styles JM; Gyure LA; Peppard J; Hobbs SM; Jackson E; Hall JG
Clin Exp Immunol; 1984 Aug; 57(2):358-64. PubMed ID: 6331924
[TBL] [Abstract][Full Text] [Related]
20. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
Carrel S; Accolla RS; Carmagnola AL; Mach JP
Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
